PNS209 IMPACT OF GENERICS AND BIOSIMILARS ON BRANDED DRUG LISTING DECISIONS IN SINGAPORE

Abstract

Authors

L.I.M. S V. Koh M. Yoshino C. Brooks Rooney

Full Text Cite This Article
Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×